Cargando…

Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats

BACKGROUND: Despite the considerable advances made in the treatment of cancer, it remains a global threat. Tartrazine (E102) is a synthetic dye widely used in food industries; it has recently been shown to induce oxidative stress (a well known risk factor of cancer) in rat tissues. The present work...

Descripción completa

Detalles Bibliográficos
Autores principales: Zingue, Stéphane, Mindang, Elisabeth Louise Ndjengue, Awounfack, Florence Charline, Kalgonbe, Abel Yanfou, Kada, Moustapha Mohamet, Njamen, Dieudonné, Ndinteh, Derek Tantoh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720219/
https://www.ncbi.nlm.nih.gov/pubmed/34972512
http://dx.doi.org/10.1186/s12906-021-03490-0
_version_ 1784625096815542272
author Zingue, Stéphane
Mindang, Elisabeth Louise Ndjengue
Awounfack, Florence Charline
Kalgonbe, Abel Yanfou
Kada, Moustapha Mohamet
Njamen, Dieudonné
Ndinteh, Derek Tantoh
author_facet Zingue, Stéphane
Mindang, Elisabeth Louise Ndjengue
Awounfack, Florence Charline
Kalgonbe, Abel Yanfou
Kada, Moustapha Mohamet
Njamen, Dieudonné
Ndinteh, Derek Tantoh
author_sort Zingue, Stéphane
collection PubMed
description BACKGROUND: Despite the considerable advances made in the treatment of cancer, it remains a global threat. Tartrazine (E102) is a synthetic dye widely used in food industries; it has recently been shown to induce oxidative stress (a well known risk factor of cancer) in rat tissues. The present work therefore aimed to assess the impact of a regular consumption of tartrazine on the incidence of breast cancer in rats. METHODS: Forty (40) Wistar rats aged 55 to 60 days were randomly assigned into 5 groups (n = 8) including two groups serving as normal controls and receiving distilled water (NOR) or tartrazine (NOR + TARZ). The three remaining groups were exposed to the carcinogen DMBA (50 mg/kg) and treated for 20 weeks with either distilled water (DMBA), tartrazine 50 mg/kg (DMBA + TARZ) or a natural dye (DMBA + COL). The parameters evaluated were the incidence, morphology and some biomarkers (CA 15–3, estradiol and α-fetoprotein) of breast cancer. The oxidative status and histomorphology of the tumors were also assessed. RESULTS: A regular intake of tartrazine led to an early incidence of tumors (100% in rats that received TARZ only vs 80% in rats that received DMBA only), with significantly larger tumors (p < 0.001) (mass = 3500 mg/kg and volume = 4 cm(3)). The invasive breast carcinoma observed on the histological sections of the animals of the DMBA + TARZ group was more developed than those of the DMBA group. The increase in serum α-fetoprotein (p < 0.05) and CA 15–3 (p < 0.01) levels corroborate the changes observed in tumors. The presence of oxidative activity in animals of the DMBA + TARZ group was confirmed by a significant decrease (p < 0.001) in the activity of antioxidant enzymes (SOD and catalase) as well as the level of GSH and increase in the level of MDA compared to the rats of the DMBA and NOR groups. CONCLUSION: Tartrazine therefore appears to be a promoter of DMBA-induced breast tumorigenesis in rats through its oxidative potential. This work encourages further studies on the mechanisms of action of tartrazine (E102) and its limits of use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03490-0.
format Online
Article
Text
id pubmed-8720219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87202192022-01-05 Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats Zingue, Stéphane Mindang, Elisabeth Louise Ndjengue Awounfack, Florence Charline Kalgonbe, Abel Yanfou Kada, Moustapha Mohamet Njamen, Dieudonné Ndinteh, Derek Tantoh BMC Complement Med Ther Research BACKGROUND: Despite the considerable advances made in the treatment of cancer, it remains a global threat. Tartrazine (E102) is a synthetic dye widely used in food industries; it has recently been shown to induce oxidative stress (a well known risk factor of cancer) in rat tissues. The present work therefore aimed to assess the impact of a regular consumption of tartrazine on the incidence of breast cancer in rats. METHODS: Forty (40) Wistar rats aged 55 to 60 days were randomly assigned into 5 groups (n = 8) including two groups serving as normal controls and receiving distilled water (NOR) or tartrazine (NOR + TARZ). The three remaining groups were exposed to the carcinogen DMBA (50 mg/kg) and treated for 20 weeks with either distilled water (DMBA), tartrazine 50 mg/kg (DMBA + TARZ) or a natural dye (DMBA + COL). The parameters evaluated were the incidence, morphology and some biomarkers (CA 15–3, estradiol and α-fetoprotein) of breast cancer. The oxidative status and histomorphology of the tumors were also assessed. RESULTS: A regular intake of tartrazine led to an early incidence of tumors (100% in rats that received TARZ only vs 80% in rats that received DMBA only), with significantly larger tumors (p < 0.001) (mass = 3500 mg/kg and volume = 4 cm(3)). The invasive breast carcinoma observed on the histological sections of the animals of the DMBA + TARZ group was more developed than those of the DMBA group. The increase in serum α-fetoprotein (p < 0.05) and CA 15–3 (p < 0.01) levels corroborate the changes observed in tumors. The presence of oxidative activity in animals of the DMBA + TARZ group was confirmed by a significant decrease (p < 0.001) in the activity of antioxidant enzymes (SOD and catalase) as well as the level of GSH and increase in the level of MDA compared to the rats of the DMBA and NOR groups. CONCLUSION: Tartrazine therefore appears to be a promoter of DMBA-induced breast tumorigenesis in rats through its oxidative potential. This work encourages further studies on the mechanisms of action of tartrazine (E102) and its limits of use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03490-0. BioMed Central 2021-12-31 /pmc/articles/PMC8720219/ /pubmed/34972512 http://dx.doi.org/10.1186/s12906-021-03490-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zingue, Stéphane
Mindang, Elisabeth Louise Ndjengue
Awounfack, Florence Charline
Kalgonbe, Abel Yanfou
Kada, Moustapha Mohamet
Njamen, Dieudonné
Ndinteh, Derek Tantoh
Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats
title Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats
title_full Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats
title_fullStr Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats
title_full_unstemmed Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats
title_short Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats
title_sort oral administration of tartrazine (e102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (dmba)-induced breast cancer in rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720219/
https://www.ncbi.nlm.nih.gov/pubmed/34972512
http://dx.doi.org/10.1186/s12906-021-03490-0
work_keys_str_mv AT zinguestephane oraladministrationoftartrazinee102acceleratestheincidenceandthedevelopmentof712dimethylbenzaanthracenedmbainducedbreastcancerinrats
AT mindangelisabethlouisendjengue oraladministrationoftartrazinee102acceleratestheincidenceandthedevelopmentof712dimethylbenzaanthracenedmbainducedbreastcancerinrats
AT awounfackflorencecharline oraladministrationoftartrazinee102acceleratestheincidenceandthedevelopmentof712dimethylbenzaanthracenedmbainducedbreastcancerinrats
AT kalgonbeabelyanfou oraladministrationoftartrazinee102acceleratestheincidenceandthedevelopmentof712dimethylbenzaanthracenedmbainducedbreastcancerinrats
AT kadamoustaphamohamet oraladministrationoftartrazinee102acceleratestheincidenceandthedevelopmentof712dimethylbenzaanthracenedmbainducedbreastcancerinrats
AT njamendieudonne oraladministrationoftartrazinee102acceleratestheincidenceandthedevelopmentof712dimethylbenzaanthracenedmbainducedbreastcancerinrats
AT ndintehderektantoh oraladministrationoftartrazinee102acceleratestheincidenceandthedevelopmentof712dimethylbenzaanthracenedmbainducedbreastcancerinrats